Quarkbio’s PanelChip® and OncoSweep™ was used in Dr. Jason Chia-Hsun Hsieh of LinKou Chang Gung Medical Hospital (CGMH)'s research to demonstrate that circulating miRNAs are powerful biomarkers for early cancer detection at ASCO 2020. Click to view the ASCO Abstract
Happy Mid Autumn Festival from QuarkBio! Our PanelChip® family hopes that everyone will have a festive and fun-filled holiday with family and loved ones. Last week we received some exciting news: our abstract was accepted at this year's ESMO Asia for an oral presentation for our work on extracellular miRNA
Happy Father's Day from QuarkBio to all the supermen in the world! A mysterious new "SuperChip" will be joining our PanelChip® family soon, can anyone guess "who" it is?
Happy Mother's Day from QuarkBio to all the superwomen that provide the base support for their family and friends! Our QuarkBio family of products will soon be increasing its size once again, as we launch a new miRNA-based product that will help create more superwomen for the world! Stay tuned
Because of miRNAs’ short length, the design of miRNA primers for PCR amplification remains a significant challenge. Adding to the challenge are miRNAs similar in sequence and miRNA family members that often only differ in sequences by 1 nt. This publication describes a novel empirical-based method, miPrimer, which greatly reduces
QuarkBio’s newest publication demonstrates the use of QuarkBio’s PanelChip™ Analysis System as a powerful technology for discovering and validating extracellular miRNA cancer biomarkers. By analyzing miRNA levels in the plasma, we were able to discover miRNA expression patterns capable of separating healthy subjects from patients with oral cavity squamous cell carcinoma. Check
QuarkBio has partnered with Min-Sheng General Hospital, one of the top hospitals in Taiwan, to implement an early stage cancer detection tool for multiple types of cancer. Min-Sheng General Hospital will be providing 1,000 clinical samples as a trial run before providing the detection test as a testing option for its